1482 related articles for article (PubMed ID: 26154167)
21. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
22. Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes.
Kim JS; Choi HW; Choi S; Seo HG; Moon SH; Chung HM; Do JT
Stem Cells Dev; 2014 Nov; 23(21):2637-48. PubMed ID: 24892478
[TBL] [Abstract][Full Text] [Related]
23. Induced pluripotent stem cells generated from human adipose-derived stem cells using a non-viral polycistronic plasmid in feeder-free conditions.
Qu X; Liu T; Song K; Li X; Ge D
PLoS One; 2012; 7(10):e48161. PubMed ID: 23110200
[TBL] [Abstract][Full Text] [Related]
24. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.
Liu K; Ji G; Mao J; Liu M; Wang L; Chen C; Liu L
Cell Reprogram; 2012 Dec; 14(6):505-13. PubMed ID: 23035653
[TBL] [Abstract][Full Text] [Related]
25. Direct reprogramming of fibroblasts into epiblast stem cells.
Han DW; Greber B; Wu G; Tapia N; Araúzo-Bravo MJ; Ko K; Bernemann C; Stehling M; Schöler HR
Nat Cell Biol; 2011 Jan; 13(1):66-71. PubMed ID: 21131959
[TBL] [Abstract][Full Text] [Related]
26. H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells.
Kunitomi A; Yuasa S; Sugiyama F; Saito Y; Seki T; Kusumoto D; Kashimura S; Takei M; Tohyama S; Hashimoto H; Egashira T; Tanimoto Y; Mizuno S; Tanaka S; Okuno H; Yamazawa K; Watanabe H; Oda M; Kaneda R; Matsuzaki Y; Nagai T; Okano H; Yagami KI; Tanaka M; Fukuda K
Stem Cell Reports; 2016 Jun; 6(6):825-833. PubMed ID: 27237376
[TBL] [Abstract][Full Text] [Related]
27. Efficient differentiation of steroidogenic and germ-like cells from epigenetically-related iPSCs derived from ovarian granulosa cells.
Anchan R; Gerami-Naini B; Lindsey JS; Ho JW; Kiezun A; Lipskind S; Ng N; LiCausi JA; Kim CS; Brezina P; Tuschl T; Maas R; Kearns WG; Williams Z
PLoS One; 2015; 10(3):e0119275. PubMed ID: 25751620
[TBL] [Abstract][Full Text] [Related]
28. CXCR2 Ligands and mTOR Activation Enhance Reprogramming of Human Somatic Cells to Pluripotent Stem Cells.
Lee SJ; Kang KW; Kim JH; Lee BH; Jung JH; Park Y; Hong SC; Kim BS
Stem Cells Dev; 2020 Feb; 29(3):119-132. PubMed ID: 31808362
[TBL] [Abstract][Full Text] [Related]
29. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
[TBL] [Abstract][Full Text] [Related]
30. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
[TBL] [Abstract][Full Text] [Related]
31. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
[TBL] [Abstract][Full Text] [Related]
32. Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.
Vazquez-Martin A; Vellon L; Quirós PM; Cufí S; Ruiz de Galarreta E; Oliveras-Ferraros C; Martin AG; Martin-Castillo B; López-Otín C; Menendez JA
Cell Cycle; 2012 Mar; 11(5):974-89. PubMed ID: 22333578
[TBL] [Abstract][Full Text] [Related]
33. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
34. An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency.
Jo J; Hwang S; Kim HJ; Hong S; Lee JE; Lee SG; Baek A; Han H; Lee JI; Lee I; Lee DR
Nucleic Acids Res; 2016 Feb; 44(3):1203-15. PubMed ID: 26740582
[TBL] [Abstract][Full Text] [Related]
35. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
Menon S; Shailendra S; Renda A; Longaker M; Quarto N
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-302 increases reprogramming efficiency via repression of NR2F2.
Hu S; Wilson KD; Ghosh Z; Han L; Wang Y; Lan F; Ransohoff KJ; Burridge P; Wu JC
Stem Cells; 2013 Feb; 31(2):259-68. PubMed ID: 23136034
[TBL] [Abstract][Full Text] [Related]
37. OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells.
Parenti A; Halbisen MA; Wang K; Latham K; Ralston A
Stem Cell Reports; 2016 Apr; 6(4):447-455. PubMed ID: 26947975
[TBL] [Abstract][Full Text] [Related]
38. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
[TBL] [Abstract][Full Text] [Related]
39. Generation of pig iPS cells: a model for cell therapy.
Montserrat N; Bahima EG; Batlle L; Häfner S; Rodrigues AM; González F; Izpisúa Belmonte JC
J Cardiovasc Transl Res; 2011 Apr; 4(2):121-30. PubMed ID: 21088946
[TBL] [Abstract][Full Text] [Related]
40. Inducing pluripotency in somatic cells from the snow leopard (Panthera uncia), an endangered felid.
Verma R; Holland MK; Temple-Smith P; Verma PJ
Theriogenology; 2012 Jan; 77(1):220-8, 228.e1-2. PubMed ID: 22079579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]